Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Conditions: Obesity; OverweightIntervention: Drug: Alli® 60 mgSponsors: GlaxoSmithKline; CRO: Hamell, The Loft, 1A Salcott Road, London SW11 6DQNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2014 Category: Research Source Type: clinical trials
Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Condition: Weight LossIntervention: Drug: Alli® 60 mgSponsors: GlaxoSmithKline; HamellNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2014 Category: Research Source Type: clinical trials
Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
Conditions: Obesity; Diabetes; Obstructive Sleep ApneaInterventions: Other: Ketogenic diet; Drug: Orlistat; Other: Standardized dietSponsor: Mid-Atlantic Epilepsy and Sleep Center, LLCRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2013 Category: Research Source Type: clinical trials
Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor
Condition: ObesityInterventions: Dietary Supplement: Control; Dietary Supplement: Capolac; Dietary Supplement: Flax fiber; Dietary Supplement: Capolac+Flax fiberSponsors: University of Copenhagen; GlaxoSmithKlineCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2011 Category: Research Source Type: clinical trials
A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
Condition: ObesityInterventions: Behavioral: Diet and Exercise; Drug: orlistat [Xenical]Sponsor: Hoffmann-La RocheCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2009 Category: Research Source Type: clinical trials
A Study of Xenical (Orlistat) in Overweight and Obese Adolescents
Condition: ObesityInterventions: Behavioral: Diet and Exercise; Drug: orlistat [Xenical]Sponsor: Hoffmann-La RocheCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2009 Category: Research Source Type: clinical trials
